The growth of Viagra and its impact on the medicinal landscape presents a complex question for shareholders. While the initial sales figures were remarkable, the exclusivity has expired, leading to a flood of generic https://emiliaylop481084.kylieblog.com/41922023/the-blue-pill-and-the-pharmaceutical-industry-a-speculative-opportunity